Laurence Digue

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

Ezra E.W. Cohen, Denis Soulières, Christophe Le Tourneau et al. · The Lancet · 2018 · 1.7K citations · Full text

Medicine, Oncology, Pharmacology +11

Positron Emission Tomography With [¹⁸F]Fluorodeoxyglucose Improves Staging and Patient Management in Patients With Head and Neck Squamous Cell Carcinoma: A Multicenter Prospective Study

Max Lonneux, Marc Hamoir, H Reychler et al. · Journal of Clinical Oncology · 2010 · 230 citations · Full text

Medicine, Nuclear Medicine, Oncology +15

Impact of the prophylactic gastrostomy for unresectable squamous cell head and neck carcinomas treated with radio-chemotherapy on quality of life: Prospective randomized trial

Sébastien Salas, Karine Baumstarck, M. Alfonsi et al. · Radiotherapy and Oncology · 2009 · 122 citations

Medicine, Oncology, Surgery +12

A multicenter phase II study of sunitinib in patients with locally advanced or metastatic differentiated, anaplastic or medullary thyroid carcinomas: mature data from the THYSU study

Alain Ravaud, Christelle de la Fouchardière, Philippe Caron et al. · European Journal of Cancer · 2017 · 110 citations

Medicine, Oncology, Endocrine Oncology +10

A prospective multicentre REFCOR study of 470 cases of head and neck Adenoid cystic carcinoma: epidemiology and prognostic factors

Sarah Atallah, Odile Casiraghi, Nicolas Fakhry et al. · European Journal of Cancer · 2020 · 85 citations · Full text

Medicine, Neck Surgery, Oncology +6